BGPT: Paper Review: Bone Marrow Involvement by Marginal Zone B-Cell Lymphomas of Different Types

Explore by Goal

Quick Explanation Copied

Bone marrow alone is insufficient to reliably subtype MZL

In a cohort of 30 BM specimens (SMZL n=18, MALT n=6, NMZL n=6), the authors report extensive overlap in BM infiltration patterns and conclude that SMZL vs MALT vs NMZL cannot be distinguished from BM sections alone; intrasinusoidal/sinusoidal infiltration and well-formed germinal centers (GCs) are supportive but not exclusive, while CD21/CD23+ follicular dendritic cell (FDC) networks are common across subtypes and therefore not discriminative.

Source:

Long Explanation

Paper Review (Rigorous): Bone Marrow Involvement by Marginal Zone B-Cell Lymphomas of Different Types

Core question: Can SMZL vs MALT lymphoma vs NMZL be reliably distinguished using bone marrow morphology and immunophenotype alone?

1) Study design & cohort (what’s actually in the data)

This is a pathology-focused, retrospectively collected cohort study using BM specimens with tissue-proven subtype classification (SMZL, MALT, NMZL).

Group	n (BM specimens)	Median BM involvement %	Inclusion logic
SMZL	18 (women 14, men 4)	15 (<5–60)	Splenectomy-proven SMZL in all cases
MALT lymphoma	6	10 (3–20)	Biopsy-proven MALT at extranodal site (stomach/salivary/breast)
NMZL	6	15 (5–60)	Node biopsy-proven NMZL (no extranodal/splenic involvement at diagnosis)

2) Key results visualized (from the paper’s extracted counts)

2A) How often each infiltration pattern occurs (overlap allowed)

Immediate interpretation: The most common patterns are nodular and interstitial across subtypes, while sinusoidal involvement is present in a subset (notably SMZL) and never appears as a dominant isolated pattern.

2B) “Single vs mixed patterns” overlap (why BM alone struggles)

The authors explicitly state that MZLs cannot be distinguished from each other by examining BM sections alone.

3) “Supportive clues” that lean toward SMZL (but don’t fully separate)

3A) Sinusoidal involvement is preferential but inconsistent

The paper emphasizes that sinusoidal infiltration is focal and always accompanies other (more prominent) patterns; reliable detection in routine H&E may require immunostains like CD20/PAX5/BSAP.

3B) Well-formed GCs are rare; FDC networks are common (therefore not subtype-discriminative)

GCs: reactive/well-formed GCs were seen in 3 SMZL cases and not in MALT or NMZL in routinely stained BM sections.
FDC networks: CD21+ or CD23+ FDC networks were present in the great majority of SMZL, and also frequently in MALT and NMZL—reducing their subtype specificity.

4) Immunophenotyping: what was discriminative vs not

The authors report a largely consistent lymphoma immunophenotype: MZL infiltrates were composed predominantly of CD20+ or PAX5/BSAP+ B cells, and (in their workup panels) the lymphoma cells were BCL-2+ and negative for CD3/CD5/CD10/cyclin D1.

4A) CD5+/CD23 aberrancies were rare and not reliably subtype-separating

Specifically, the paper describes CD5 positivity in only 1 SMZL case and 1 NMZL case, with additional nuance (e.g., a CD5+ SMZL case with dim CD23 expression; and a CD5+ NMZL case without coexpression of CD23).

5) Diagnostic takeaways (what can change your confidence)

5A) “BM-only” classification confidence is limited

Overlap is the default: nodular/interstitial patterns dominate across subtypes, and most cases show mixed infiltration patterns.
Therefore: BM morphology alone cannot reliably subtype MZL types.

5B) What increases likelihood of SMZL (but remains non-exclusive)

Sinusoidal/intrasinusoidal pattern: supportive when seen and often requires immunostains for reliable detection; focal and typically accompanied by other patterns.
Well-formed GCs in routine sections: observed only in a minority of SMZL cases and thus not sufficient by itself.
CBC correlation: the authors suggest correlation with CBC can enhance SMZL reliability (e.g., peripheral lymphocytosis/anemia patterns differing by subtype), but BM findings remain overlapping.

6) Critical appraisal (skeptical, scientific, and specific)

Strengths

Subtype verification via splenectomy or tissue biopsy/specified sites for SMZL/MALT/NMZL decreases misclassification risk compared with studies lacking tissue confirmation.
Explicit operational definitions for infiltration patterns (nodular, interstitial, diffuse, paratrabecular, sinusoidal) support reproducibility of pattern calling within pathology practice.
Integrated morphologic + immunophenotypic evaluation addresses the real-world limitation of small biopsy specimens.

Key limitations / blind spots

Small and unequal group sizes for MALT and NMZL (n=6 each) limit statistical confidence and sensitivity to detect subtype-specific signals.
Selection bias: the cohort includes only BM-positive specimens with tissue-proven subtype (not the full spectrum of patients undergoing BM for staging). This can overestimate “overlap within BM” or underestimate discriminative features that appear only in broader settings.
Observer and definition sensitivity: sinusoidal thresholds and detection depend on immunostaining and section quality; subtle features may be missed in routine H&E, and pattern overlap could increase with less standardized workflows.
FDC networks aren’t specific by design: CD21/CD23+ FDC networks were common across subtypes, limiting diagnostic leverage of these markers.
Limited marker breadth (as presented) for distinguishing MZL subtypes may leave unmeasured biological differences unresolved. The study focuses on CD20/PAX5, CD21/CD23, and selected routine markers; other discriminative candidates may exist outside these panels.

What would disprove/reshape the take-home message?

A larger, prospectively standardized multicenter cohort using consistent staining panels and blinded pattern scoring could show subtype-discriminative features in BM that this small study could not detect (or could confirm overlap more strongly). The authors’ own conclusion—BM alone cannot reliably subtype—would be strengthened or weakened depending on external replication.

Author Review Links

Explore deeper author-focused critiques via BGPT:

Feedback:

Updated: April 15, 2026